Excess COVID-19 death risk from type 2 diabetes decreases with increasing age
XDR Typhoid Fever Cases Found in the USA
The US Centers for Disease Control and Prevention (CDC) announced nine extensively drug-resistant (XDR) typhoid fever cases in the USA unrelated to international travel.
Additionally, the CDC’s Health Advisory Network issued an Alert on February 12, 2021, stating an ongoing outbreak of XDR typhoid fever has sickened more than 5,000 people in the Islamic Republic of Pakistan since 2016.
Veklury Use While Pregnant to be Studied
A recent study funded by the National Institutes of Health (NIH) will evaluate the effects of Veklury (remdesivir) in pregnant women who are being treated for COVID-19.
This NIH study announced on February 17, 2021, aims to determine how pregnant women metabolize Veklury and any potential side effects.
The study will be conducted at 17 sites in the continental United States and Puerto Rico. It will be led by the NIH-funded International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network.
Many U.S. Troops Refusing COVID-19 Vaccination
Up to two-thirds of troops who were offered the vaccine have accepted, according to ‘very early data’
Age, Frailty Independently Linked to COVID-19 Mortality
Frailty also associated with increased risk for higher care needs on discharge and increased likelihood of adverse outcomes
Myocardial Injury Prevalent in Patients With Severe COVID-19
54 percent of discharged patients who had troponin elevation in conjunction with severe COVID-19 had late gadolinium enhancement and/or ischemia
Expanded Collaboration to Advance New Therapeutics for Respiratory Viruses
Vir Biotechnology, Inc. and GlaxoSmithKline plc (GSK) announced an agreement to expand their existing collaboration to include the research and development of new therapies for influenza and other respiratory viruses.
Expanded Collaboration to Advance New Therapeutics for Respiratory Viruses
Vir Biotechnology, Inc. and GlaxoSmithKline plc (GSK) announced an agreement to expand their existing collaboration to include the research and development of new therapies for influenza and other respiratory viruses.
Editorial: U.S. FDA’s Experience with COVID-19 Antibody Tests
An editorial published by The New England Journal of Medicine (NEJM) highlights ‘establishing robust and coordinated national and international mechanisms for generating evidence and gathering, sharing, and disseminating information will be critical to ending the current pandemic and addressing future public health emergencies.’
Prevalence of SARS-CoV-2 Infection Low in Young Children
Few children or day care center staff had SARS-CoV-2 infection during lockdown; seropositive children more likely exposed at home